HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effects of the selective chymase inhibitor TEI-F00806 on the intrarenal renin-angiotensin system in salt-treated angiotensin I-infused hypertensive mice.

AbstractNEW FINDINGS:
What is the central question of this study? Can chymase inhibition prevent angiotensin I-induced hypertension through inhibiting the conversion of angiotensin I to angiotensin II in the kidney? What is the main finding and its importance? Treatment with TEI-F00806 decreased angiotensin II content of the kidney, renal cortical angiotensinogen protein levels and chymase mRNA expression, and attenuated the development of hypertension.
ABSTRACT:
The effects of the selective chymase inhibitor TEI-F00806 were examined on angiotensin I (Ang I)-induced hypertension and intrarenal angiotensin II (Ang II) production in salt-treated mice. Twelve-week-old C57BL male mice were given a high-salt diet (4% NaCl + saline (0.9% NaCl)), and divided into three groups: (1) sham + vehicle (5% acetic acid in saline), (2) Ang I (1 μg kg-1  min-1 , s.c.) + vehicle, and (3) Ang I + TEI-F00806 (100 mg kg-1  day-1 , p.o.) (n = 8-10 per group). Systolic blood pressure was measured weekly using a tail-cuff method. Kidney Ang II content was measured by radioimmunoassay. Chronic infusion of Ang I resulted in the development of hypertension (P < 0.001), and augmented intrarenal chymase gene expression (P < 0.05), angiotensinogen protein level (P < 0.001) and Ang II content (P < 0.01) in salt-treated mice. Treatment with TEI-F00806 attenuated the development of hypertension (P < 0.001) and decreased Ang II content of the kidney (P < 0.05), which was associated with reductions in renal cortical angiotensinogen protein levels (P < 0.001) and chymase mRNA expression (P < 0.05). These data suggest that a chymase inhibitor decreases intrarenal renin-angiotensin activity, thereby reducing salt-dependent hypertension.
AuthorsTuba M Ansary, Maki Urushihara, Yoshihide Fujisawa, Sayaka Nagata, Hidenori Urata, Daisuke Nakano, Hitomi Hirofumi, Kazuo Kitamura, Shoji Kagami, Akira Nishiyama
JournalExperimental physiology (Exp Physiol) Vol. 103 Issue 11 Pg. 1524-1531 (11 2018) ISSN: 1469-445X [Electronic] England
PMID30137655 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2018 The Authors. Experimental Physiology © 2018 The Physiological Society.
Chemical References
  • Angiotensin II
  • Angiotensin I
  • Peptidyl-Dipeptidase A
  • Chymases
Topics
  • Angiotensin I
  • Angiotensin II (metabolism)
  • Animals
  • Blood Pressure (drug effects)
  • Chymases (antagonists & inhibitors, metabolism)
  • Hypertension (chemically induced, drug therapy, metabolism)
  • Kidney (drug effects, metabolism)
  • Male
  • Mice
  • Peptidyl-Dipeptidase A (metabolism)
  • Renin-Angiotensin System (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: